Rizwan Velji

Mr. Rizwan Velji joined Burrill & Company from the Human Molecular Genetics Department at Baylor College of Medicine.
At Baylor, Mr. Velji served as Research Assistant with the Adenoviral Vector Gene Therapy Group, with a special focus on its production and delivery capabilities as a therapeutic.
As a member of the Burrill team, Mr. Velji plays an active role with the Venture Capital Group and also plays an instrumental role with respect to Burrill's growing biotech research activities.
Mr. Velji received his B.Sc.
in Physiology with First Class Honors from McGill University and an MS in Biotechnology from Northwestern University.